A deep learning model using echocardiography accurately detects cardiac amyloidosis, outperforming traditional methods.
Key Details
- 1AI model trained on echocardiography video clips from 2,612 patients across multiple sites and ethnic groups.
- 2External validation performed on 18 global sites; included 597 amyloidosis cases and 2,122 controls.
- 3Achieved AUROC of 0.93 (after excluding 13% uncertain predictions), sensitivity of 85%, specificity of 93%.
- 4Performance was consistent across amyloidosis subtypes and various subgroups.
- 5The AI model outperformed transthyretin cardiac amyloidosis (TTR-CA) score (AUROC = 0.73) and wall thickness scoring (AUROC = 0.8).
- 6Ultromics employees contributed and funded the study.
Why It Matters

Source
AuntMinnie
Related News

Stanford Team Introduces Real-Time AI Safety Monitoring for Radiology
Stanford researchers introduced an ensemble monitoring model to provide real-time confidence assessments for FDA-cleared radiology AI tools.

Harrison.ai Receives FDA Breakthrough Status for Imaging AI Device
Harrison.ai has been awarded three FDA breakthrough device designations for its imaging AI solutions, including a tool for obstructive hydrocephalus triage.

Head-to-Head Study Evaluates AI Accuracy in Fracture Detection on X-Ray
A prospective study compared three commercial AI tools for fracture detection on x-ray, showing moderate-to-high accuracy for simple cases but weaker performance in complex scenarios.